The effectiveness of the Pfizer / BioNTech vaccine against SARS-CoV-2 infection fell to 39% between June 20 and July 17 in Israel, the Ministry of Health announced on Thursday, noting that finds this finding at a time when the most contagious Delta variant is spreading.
Prevention of serious forms
This percentage is significantly lower than the 64% that was mentioned from June 6 to July 3 and the 94.3% that was measured from May 2 to June 5.
However, the effectiveness of the US-Germany consortium in preventing severe forms of COVID-19 is estimated at 91.4% and its effectiveness in preventing hospital admissions is estimated at 88%, according to Ministry estimates.
Since the start of the vaccination campaign in Israel on December 20, 2020, more than 5.75 million people, or 61.6% of the population, have received the first dose of the vaccine, of which 5, 28 million and the second.
The evolution of the pandemic
In the last 24 hours, 1,275 cases of SARS-CoV-2 were diagnosed, bringing the total number of infections to 856,827, while three more patients with COVID-19 succumbed, accounting for the number of killed by pandemic at 6,457.
The number of active cases rose to 9,742, the highest level since March 27.
In addition, the number of patients treated in severe condition increased to 75 (+7).